ITMCTR2100005305
Not Yet Recruiting
Phase 4
A prospective, multicenter, large sample, registry-based clinical trial design to evaluate the efficacy and safety of Angong Niuhuang Pill in the acute phase of stroke
Integrated Hospital of Traditional Chinese Medicine, Southern Medical University0 sitesTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Integrated Hospital of Traditional Chinese Medicine, Southern Medical University
- Status
- Not Yet Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. The subject was clinically diagnosed with acute stage of stroke and the responsible lesion (infarct or hemorrhage foci) appeared on imaging, and the subject was prescribed Angong Niuhuang Pills for more than 3 days.
- •2\. The Chinese medicine diagnosis is phlegm\-heat internal closure evidence
- •3\. Subjects voluntarily enrolled in this study and signed a written informed consent form.
Exclusion Criteria
- •1\. Patients with stroke caused by brain tumor, traumatic brain injury, hematological disease, rheumatic heart disease, coronary heart disease and other heart disease combined with atrial fibrillation.
- •2\. Other patients who are considered by the investigator to be inappropriate for participation in this study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
A Registry of Participants with Prostate Cancer in AsiaHealth Condition 1: null- Prostate cancerCTRI/2018/01/011570Janssen Research Development LLC
Recruiting
N/A
Metastatic ColoRectal cancer India RegistryHealth Condition 1: C189- Malignant neoplasm of colon, unspecifiedCTRI/2022/07/043968Dr Reddys Laboratories
Completed
N/A
An Observational prospective Multicenter registry study on Outcomes of peripheral arTErial disease patieNts treated by AngioplaSty tHerapy in aortoIliac arteryPeripheral artery diseaseJPRN-UMIN000013849Research group on endovascular treatment in aortiliac artery1,500
Active, Not Recruiting
N/A
A Multicenter, Prospective, Long-term Registry of children with Crohn's Disease or Ulcerative ColitisEUCTR2008-005237-30-NLJanssen Biologics B.V.6,000
Active, Not Recruiting
N/A
A Multicenter, Prospective, Long-term Registry of children with Crohn's DiseasePediatric patients with a confirmed diagnosis of CD aged 6 years to lessthan 17 years of age at the time of enrollmentMedDRA version: 14.0Level: LLTClassification code 10013099Term: Disease CrohnsSystem Organ Class: 10017947 - Gastrointestinal disordersTherapeutic area: Diseases [C] - Digestive System Diseases [C06]EUCTR2008-005237-30-SEJanssen Biologics BV4,000